Literature DB >> 22760919

The major histocompatibility complex and autism spectrum disorder.

Leigh A Needleman1, A Kimberley McAllister.   

Abstract

Autism spectrum disorder (ASD) is a complex disorder that appears to be caused by interactions between genetic changes and environmental insults during early development. A wide range of factors have been linked to the onset of ASD, but recently both genetic associations and environmental factors point to a central role for immune-related genes and immune responses to environmental stimuli. Specifically, many of the proteins encoded by the major histocompatibility complex (MHC) play a vital role in the formation, refinement, maintenance, and plasticity of the brain. Manipulations of levels of MHC molecules have illustrated how disrupted MHC signaling can significantly alter brain connectivity and function. Thus, an emerging hypothesis in our field is that disruptions in MHC expression in the developing brain caused by mutations and/or immune dysregulation may contribute to the altered brain connectivity and function characteristic of ASD. This review provides an overview of the structure and function of the three classes of MHC molecules in the immune system, healthy brain, and their possible involvement in ASD.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22760919      PMCID: PMC4365477          DOI: 10.1002/dneu.22046

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  139 in total

1.  Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.

Authors:  Elias T Spiliotis; Tsvetelina Pentcheva; Michael Edidin
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

2.  Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort.

Authors:  Morsi W Abdallah; Nanna Larsen; Jakob Grove; Bent Nørgaard-Pedersen; Poul Thorsen; Erik L Mortensen; David M Hougaard
Journal:  Brain Behav Immun       Date:  2011-09-10       Impact factor: 7.217

Review 3.  Heat shock proteins: cellular and molecular mechanisms in the central nervous system.

Authors:  R Anne Stetler; Yu Gan; Wenting Zhang; Anthony K Liou; Yanqin Gao; Guodong Cao; Jun Chen
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

4.  Possible association of the extended MHC haplotype B44-SC30-DR4 with autism.

Authors:  R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; C W DeWitt; M McCullough
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

Review 6.  The neuropoietic cytokine family in development, plasticity, disease and injury.

Authors:  Sylvian Bauer; Bradley J Kerr; Paul H Patterson
Journal:  Nat Rev Neurosci       Date:  2007-03       Impact factor: 34.870

7.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

8.  Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Authors:  Paul Ashwood; Amanda Enstrom; Paula Krakowiak; Irva Hertz-Picciotto; Robin L Hansen; Lisa A Croen; Sally Ozonoff; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

9.  Hsp70 and its molecular role in nervous system diseases.

Authors:  Giuseppina Turturici; Gabriella Sconzo; Fabiana Geraci
Journal:  Biochem Res Int       Date:  2011-02-24

10.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.

Authors:  Paula E Goines; Lisa A Croen; Daniel Braunschweig; Cathleen K Yoshida; Judith Grether; Robin Hansen; Martin Kharrazi; Paul Ashwood; Judy Van de Water
Journal:  Mol Autism       Date:  2011-08-02       Impact factor: 7.509

View more
  28 in total

1.  MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease.

Authors:  Bradford M Elmer; Myka L Estes; Stephanie L Barrow; A Kimberley McAllister
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

2.  Respiratory viral infection in neonatal piglets causes marked microglia activation in the hippocampus and deficits in spatial learning.

Authors:  Monica R P Elmore; Michael D Burton; Matthew S Conrad; Jennifer L Rytych; William G Van Alstine; Rodney W Johnson
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

3.  A genome-wide association study reveals a substantial genetic basis underlying the Ebbinghaus illusion.

Authors:  Zijian Zhu; Biqing Chen; Ren Na; Wan Fang; Wenxia Zhang; Qin Zhou; Shanbi Zhou; Han Lei; Ailong Huang; Tingmei Chen; Dongsheng Ni; Yuping Gu; Jianing Liu; Yi Rao; Fang Fang
Journal:  J Hum Genet       Date:  2020-09-16       Impact factor: 3.172

4.  Microglia from offspring of dams with allergic asthma exhibit epigenomic alterations in genes dysregulated in autism.

Authors:  Annie Vogel Ciernia; Milo Careaga; Janine M LaSalle; Paul Ashwood
Journal:  Glia       Date:  2017-11-14       Impact factor: 7.452

5.  CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging.

Authors:  Colleen A Mangold; Dustin R Masser; David R Stanford; Georgina V Bixler; Aditya Pisupati; Cory B Giles; Jonathan D Wren; Matthew M Ford; William E Sonntag; Willard M Freeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-18       Impact factor: 6.053

Review 6.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Nat Rev Neurosci       Date:  2015-08       Impact factor: 34.870

7.  Human microglia states are conserved across experimental models and regulate neural stem cell responses in chimeric organoids.

Authors:  Galina Popova; Sarah S Soliman; Chang N Kim; Matthew G Keefe; Kelsey M Hennick; Samhita Jain; Tao Li; Dario Tejera; David Shin; Bryant B Chhun; Christopher S McGinnis; Matthew Speir; Zev J Gartner; Shalin B Mehta; Maximilian Haeussler; Keith B Hengen; Richard R Ransohoff; Xianhua Piao; Tomasz J Nowakowski
Journal:  Cell Stem Cell       Date:  2021-09-17       Impact factor: 25.269

Review 8.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

Review 9.  Major histocompatibility complex I in brain development and schizophrenia.

Authors:  A Kimberley McAllister
Journal:  Biol Psychiatry       Date:  2013-10-10       Impact factor: 13.382

10.  Maternal mid-gestational and child cord blood immune signatures are strongly associated with offspring risk of ASD.

Authors:  Xiaoyu Che; Mady Hornig; Michaeline Bresnahan; Camilla Stoltenberg; Per Magnus; Pål Surén; Siri Mjaaland; Ted Reichborn-Kjennerud; Ezra Susser; W Ian Lipkin
Journal:  Mol Psychiatry       Date:  2022-01-05       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.